CASP3 and metabolic dysfunction-associated steatotic liver disease: CSEE at a concentration of 0.1–0.2 mg/ml markedly down-regulated the gene expressions of CASP3, EGFR, and APP and up-regulated that of PIK3CA in the in vitro model of NAFLD.